Resolve Medicolegal Limited - Accounts to registrar (filleted) - small 22.3

REGISTERED NUMBER: SC432222 (Scotland)

UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 30 SEPTEMBER 2022

FOR

RESOLVE MEDICOLEGAL LIMITED

Page

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

4

DIRECTORS:

Mr M Broadbent

Mr P M S Simpson

Mr D Q Donaldson

Mr R A E Clayton

REGISTERED OFFICE:

c/o Mr M Broadbent

No 2, The Arc

25 Colquhoun Avenue

Hillington Park

Glasgow

G52 4BN

REGISTERED NUMBER:

SC432222 (Scotland)

FIXED ASSETS

Tangible assets

4

9,318

9,653

CURRENT ASSETS

Debtors

5

103,223

116,085

Cash at bank

176,102

194,573

279,325

310,658

CREDITORS

Amounts falling due within one year

6

102,595

110,366

NET CURRENT ASSETS

176,730

200,292

TOTAL ASSETS LESS CURRENT LIABILITIES

186,048

209,945

PROVISIONS FOR LIABILITIES

1,696

1,834

NET ASSETS

184,352

208,111

CAPITAL AND RESERVES

Called up share capital

7

100

100

Retained earnings

184,252

208,011

SHAREHOLDERS' FUNDS

184,352

208,111

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 September 2022.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 September 2022 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 2 December 2022 and were signed on its behalf by:

Mr M Broadbent - Director

1.	STATUTORY INFORMATION

Resolve Medicolegal Limited is a private company, limited by shares , registered in Scotland. The company's registered number and registered office address can be found on the Company Information page.

2.	ACCOUNTING POLICIES

BASIS OF PREPARING THE FINANCIAL STATEMENTS

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

RELATED PARTY EXEMPTION

The company has taken advantage of exemption, under the terms of Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland', not to disclose related party transactions with wholly owned subsidiaries within the group.

TURNOVER

The turnover shown in the profit and loss account represents amount earned during the year and is recognised when the company obtains the right to consideration.

TANGIBLE FIXED ASSETS

Depreciation is provided at the following annual rates in order to write off the cost less estimated residual value of each asset over its estimated useful life.

Improvements to property

-

20% on cost

Fixtures and fittings

-

15% on reducing balance

All fixed assets are initially recorded at cost.

TAXATION

Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

DEFERRED TAX

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

PENSION COSTS AND OTHER POST-RETIREMENT BENEFITS

The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 18 (2021 - 17 ) .

4.	TANGIBLE FIXED ASSETS

Improvements

Fixtures

to

and

property

fittings

Totals

£

£

£

COST

At 1 October 2021

20,346

23,823

44,169

Additions

-

1,310

1,310

At 30 September 2022

20,346

25,133

45,479

DEPRECIATION

At 1 October 2021

20,346

14,170

34,516

Charge for year

-

1,645

1,645

At 30 September 2022

20,346

15,815

36,161

NET BOOK VALUE

At 30 September 2022

-

9,318

9,318

At 30 September 2021

-

9,653

9,653

5.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2022

2021

£

£

Trade debtors

69,820

78,693

Prepayments and accrued income

33,403

37,392

103,223

116,085

6.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2022

2021

£

£

Tax

18,257

11,549

VAT

37,221

55,666

Accrued expenses

47,117

43,151

102,595

110,366

7.	CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:

Number:

Class:

Nominal

2022

2021

value:

£

£

100

Ordinary

£1

100

100

8.	RELATED PARTY DISCLOSURES

Throughout the year the company paid £18,000 (2021 - £18,000) to Broadbent Legal Services Limited, a company in which Mr Broadbent is a Director and Shareholder, for Management Consultancy. The balance owing as at the balance sheet date was £Nil (2021 - £Nil).

Throughout the year the company paid £6,000 (2021 - £6,000) to Simpsons Orthopaedics Limited, a company in which Mr Simpson is a Director and Shareholder, for Management Consultancy. The balance owing as at the balance sheet date was £Nil (2021 - £Nil)

Throughout the year the company paid £6,000 (2021 - £6,000) to Mr D Donaldson for Management Consultancy. The balance owing as at the balance sheet date was £Nil (2021 - £Nil)

Throughout the year the company paid £6,000 (2021 - £6,000) to Clayton Medical, a company in which Mr Clayton is a Director and Shareholder, for Management Consultancy. The balance owing as at the balance sheet date was £Nil (2021 - £Nil).